Recipharm is a leading CDMO with 3,500 employees, offering manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, and pharmaceutical product development. Recipharm operates facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Sweden. Recipharm has extensive experience in medicinal chemistry including specialities such as ADC offerings, radiolabelling and non-GMP scale up chemistry.
Quanta BioDesign was founded for the purpose of developing a line of products involved in drug discovery and diagnostic development. For 30 years the PEGylation of biologics has been completely defined by the use of generally high MW and highly polydispersed PEGs. While showing promising results in the clinic, it has serious limitations in control and characterization. Our single molecular weight ethylene glycol conjugation technology, dPEG, can eliminate common problems found in the development of diagnostic and therapeutic products.
SCIEX offers an innovative set of LC, MS, CE, software, and compliance and validation solutions to meet the demands of modern therapeutic discovery and development. From accurate DAR measurement and comprehensive characterization to streamlined biotransformation solution to integrated Qual/Quant and low-level quantitation of antibody drug conjugates (ADC), SCIEX provides innovative solutions to simplify your analyses and accelerate your ADC program.
At Sutro Biopharma we have pioneered a compelling and unique way of discovering, developing and manufacturing therapeutics. Our focus is aimed primarily on next generation cancer therapeutics — Antibody Conjugates and Bispecific Antibodies. Unconstrained by traditional methods of cell-based discovery, we can… Read more
Syngene International Limited is the largest Contract Research Organization of India offering a suite of integrated, end-to-end discovery and development services for novel molecular entities across small and large molecules, antibody-drug conjugates and oligonucleotides. Our nearly 300 global clientele covers diverse sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies… Read more